NUSCALE POWER CORP (SMR)

US67079K1007 - Common Stock

21.08  +0.07 (+0.33%)

Fundamental Rating

4

Taking everything into account, SMR scores 4 out of 10 in our fundamental rating. SMR was compared to 88 industry peers in the Electrical Equipment industry. No worries on liquidiy or solvency for SMR as it has an excellent financial health rating, but there are worries on the profitability. SMR is quite expensive at the moment. It does show a decent growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SMR has reported negative net income.
In the past year SMR has reported a negative cash flow from operations.
SMR had negative earnings in each of the past 5 years.
In the past 5 years SMR always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -31.74%, SMR is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
With a Return On Equity value of -50.23%, SMR perfoms like the industry average, outperforming 46.59% of the companies in the same industry.
Industry RankSector Rank
ROA -31.74%
ROE -50.23%
ROIC N/A
ROA(3y)-39.32%
ROA(5y)-79.91%
ROE(3y)-78.29%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 22.50%, SMR is in line with its industry, outperforming 53.41% of the companies in the same industry.
SMR's Gross Margin has declined in the last couple of years.
SMR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.01%
GM growth 5YN/A

More info and screens

8

2. Health

2.1 Basic Checks

SMR does not have a ROIC to compare to the WACC, probably because it is not profitable.
SMR has more shares outstanding than it did 1 year ago.
SMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 30.79 indicates that SMR is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 30.79, SMR belongs to the top of the industry, outperforming 96.59% of the companies in the same industry.
There is no outstanding debt for SMR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 30.79
ROIC/WACCN/A
WACC10.27%

2.3 Liquidity

SMR has a Current Ratio of 2.24. This indicates that SMR is financially healthy and has no problem in meeting its short term obligations.
SMR has a better Current ratio (2.24) than 64.77% of its industry peers.
A Quick Ratio of 2.24 indicates that SMR has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.24, SMR belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 2.24

More info and screens

5

3. Growth

3.1 Past

SMR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -25.00%.
Looking at the last year, SMR shows a very negative growth in Revenue. The Revenue has decreased by -65.99% in the last year.
SMR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 236.25% yearly.
EPS 1Y (TTM)-25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.77%
Revenue 1Y (TTM)-65.99%
Revenue growth 3Y236.25%
Revenue growth 5YN/A
Sales Q2Q%-93.17%

3.2 Future

The Earnings Per Share is expected to grow by 17.80% on average over the next years. This is quite good.
Based on estimates for the next years, SMR will show a very strong growth in Revenue. The Revenue will grow by 88.45% on average per year.
EPS Next Y8.5%
EPS Next 2Y14.33%
EPS Next 3Y12.8%
EPS Next 5Y17.8%
Revenue Next Year-38.53%
Revenue Next 2Y52.45%
Revenue Next 3Y89.18%
Revenue Next 5Y88.45%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SMR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SMR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

SMR's earnings are expected to grow with 12.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.33%
EPS Next 3Y12.8%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SMR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NUSCALE POWER CORP

NYSE:SMR (12/26/2024, 10:40:08 AM)

21.08

+0.07 (+0.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners46.37%
Inst Owner Change16.37%
Ins Owners1.24%
Ins Owner Change0.36%
Market Cap5.38B
Analysts73.33
Price Target18.14 (-13.95%)
Short Float %20.6%
Short Ratio1.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-107.48%
Min EPS beat(2)-127.36%
Max EPS beat(2)-87.6%
EPS beat(4)0
Avg EPS beat(4)-81.92%
Min EPS beat(4)-127.36%
Max EPS beat(4)-22.31%
EPS beat(8)1
Avg EPS beat(8)-180.31%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-85.57%
Min Revenue beat(2)-86.13%
Max Revenue beat(2)-85.02%
Revenue beat(4)0
Avg Revenue beat(4)-75.49%
Min Revenue beat(4)-86.13%
Max Revenue beat(4)-54.74%
Revenue beat(8)0
Avg Revenue beat(8)-66.47%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)33.87%
PT rev (3m)71.02%
EPS NQ rev (1m)0%
EPS NQ rev (3m)26.92%
EPS NY rev (1m)-20.39%
EPS NY rev (3m)-72.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-89.17%
Revenue NY rev (1m)36.37%
Revenue NY rev (3m)25.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 729.3
P/FCF N/A
P/OCF N/A
P/B 33.63
P/tB 40.12
EV/EBITDA N/A
EPS(TTM)-0.95
EYN/A
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS0.03
BVpS0.63
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.74%
ROE -50.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.5%
FCFM N/A
ROA(3y)-39.32%
ROA(5y)-79.91%
ROE(3y)-78.29%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.01%
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.7%
Cap/Sales 0.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.24
Quick Ratio 2.24
Altman-Z 30.79
F-Score3
WACC10.27%
ROIC/WACCN/A
Cap/Depr(3y)80.8%
Cap/Depr(5y)90.7%
Cap/Sales(3y)31.83%
Cap/Sales(5y)195.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.77%
EPS Next Y8.5%
EPS Next 2Y14.33%
EPS Next 3Y12.8%
EPS Next 5Y17.8%
Revenue 1Y (TTM)-65.99%
Revenue growth 3Y236.25%
Revenue growth 5YN/A
Sales Q2Q%-93.17%
Revenue Next Year-38.53%
Revenue Next 2Y52.45%
Revenue Next 3Y89.18%
Revenue Next 5Y88.45%
EBIT growth 1Y27.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.84%
EBIT Next 3Y16.65%
EBIT Next 5Y16.11%
FCF growth 1Y-17.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.13%
OCF growth 3YN/A
OCF growth 5YN/A